Merck & Co (MRK)

$81.75 1.44 (1.79%)

9:16 EDT MRK Stock Quote Delayed 20 Minutes

Volume:

Previous Close $80.31

Market Cap 219.93B

PE Ratio 140.95

EPS 0.58

Volume (Avg. Vol.) 14,067

Day's Range 80.31 - 80.31

52-Week Range 65.25 - 92.64

Dividend & Yield 1.92 (2.35%)

MRK Stock Predictions, Articles, and Merck & Co News

From InvestorPlace
From the Web

Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks

By Todd Shriber, InvestorPlace Contributor Mar 30, 2020

Friday was a down day, but four of the past five have been up days for the Dow and it's worth pointing out that after one of the most rapid corrections/bear markets on record, plenty of bad news is already being consumed, but plenty of uncertainty lingers, too.

Dow Jones Today: Stocks Rally as Coronavirus National Emergency Looms

By Todd Shriber, InvestorPlace Contributor Mar 13, 2020

Stocks popped Friday as investors sought coronavirus clarity from the White House and speculated the Fed could cut rates to zero.

3 Big Stock Charts for Tuesday: Merck, Nucor, and BorgWarner

By Vince Martin, InvestorPlace Contributor Feb 18, 2020

Tuesday's 3 big stock charts feature suddenly unloved names that have traded back to past lows — and thus need support to hold.

3 Dow Jones Industrial Average Stocks to Sell

By William Roth, InvestorPlace Market Strategist Feb 13, 2020

With China's coronavirus weighing on global equities, these Dow Jones stocks like MMM and JNJ are great names to sell.

Merck’s Spinoff Promises Higher Dividends and Big Upside

By Mark R. Hake, CFA Feb 13, 2020

Merck's proposed spinoff of women's health and other prescription drug businesses looks to boost growth and upside for MRK stock.

Merck’s Spinoff Plans Place a Big Bet on Cancer-Fighting Keytruda

By Dana Blankenhorn, InvestorPlace Contributor Feb 6, 2020

Merck stock fell on news it will spin off slow-growth areas to focus on Keytruda, its anti-cancer immunotherapy blockbuster.

Compare Brokers

Merck Earnings: MRK Stock Moves 4% Lower on Spin-Off News

By William White, InvestorPlace Writer Feb 5, 2020

Merck (MRK) earnings for the healthcare company's fourth quarter of 2019 have MRK stock down Wednesday on major spin-off news.

5 Great Blue-Chip Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Jan 29, 2020

In this volatile market, blue-chip stocks will get you through. Here are five of the bluest stocks to buy today.

3 Healthcare Stocks Under Pressure from Bernie

By William Roth, InvestorPlace Market Strategist Jan 27, 2020

These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.

A Recent FDA Approval Will Be Huge in Moving Amarin Stock

By Chris Lau, InvestorPlace Contributor Jan 9, 2020

FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.

3 Stocks to Buy That Will Hit New All-Time Highs in 2020

By Vince Martin, InvestorPlace Contributor Jan 8, 2020

Though the market is at all-time highs, not every stock can say the same. These three stocks to buy should reach new peaks in 2020.

3 of the Best Healthcare Stocks to Buy in 2020

By Tyler Craig, Tales of a Technician Jan 2, 2020

Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.

Compare Brokers

Dow Jones Today: Data Does It Again

By Todd Shriber, InvestorPlace Contributor Dec 20, 2019

Some solid consumer sentiment and spending reports boosted stocks to close the week, although gains were modest.

3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries

By Vince Martin, InvestorPlace Contributor Oct 31, 2019

Thursday's 3 big stock charts highlight 3 recent movers that could rally if broad market optimism continues.

Dow Jones Today: Struggling at the Highs

By Todd Shriber, InvestorPlace Contributor Oct 29, 2019

Some of today's malaise can be attributed to Alphabet (NASDAQ:GOOGL,GOOG), which declined following a disappointing earnings report issued yesterday after the market closed. The internet search giant reported earnings of $10.12 a share on revenue of $40.50 billion while analysts expected earnings of $12.42 on revenue of $40.32 billion.